A phase III, variable-dose titration followed by a randomized double-blind study of controlled-release OROS hydromorphone HCl (NMED-1077) compared to placebo in patients with chronic low back pain.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Jun 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

30 Apr 2010 Results published in Current Medical Research and Opinion.
07 May 2009 Abstract presented at the 28th Annual Scientific Meeting of the American Pain Society (APS 2009).
23 Mar 2009 Results reported by Neuromed Pharmaceuticals.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com